Benzinga Generic Drugs Focused Amneal Pharmaceuticals Revenue Crosses $800 Million
Amneal beats fourth-quarter earnings and revenue estimates, driven by CREXONT sales, and guides up to $1.03 in 2026 earnings. Importance Rank: 1 read more
Amneal beats fourth-quarter earnings and revenue estimates, driven by CREXONT sales, and guides up to $1.03 in 2026 earnings. Importance Rank: 1 read more